Approved Formulary
Add Formweb to your mobile device
Approved Formulary
Do Not Crush Sustained release tablets may not be crushed, but are scored and may be broken in half. Sustained release capsules may be opened and contents taken without crushing or chewing.
Search results for:
VERAPAMIL
VERAPAMIL
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| VERELAN PM | CAPSULE, EXTENDED RELEASE | 100 mg/24 hours | ||
| VERELAN | CAPSULE, EXTENDED RELEASE | 120 mg | ||
| VERELAN | CAPSULE, EXTENDED RELEASE | 180 mg | ||
| VERELAN PM | CAPSULE, EXTENDED RELEASE | 200 mg | ||
| VERELAN | CAPSULE, EXTENDED RELEASE | 240 mg | ||
| VERELAN PM | CAPSULE, EXTENDED RELEASE | 300 mg/24 hours | ||
| VERELAN | CAPSULE, EXTENDED RELEASE | 360 mg | ||
| VERAPAMIL HYDROCHLORIDE | INJECTION | 2.5 mg/ml | ||
| VERAPAMIL HYDROCHLORIDE | TABLET | 40 mg | ||
| VERAPAMIL HYDROCHLORIDE | TABLET | 80 mg | ||
| VERAPAMIL HYDROCHLORIDE | TABLET | 120 mg | ||
| CALAN SR | TABLET, EXTENDED RELEASE | 120 mg | ||
| ISOPTIN SR | TABLET, EXTENDED RELEASE | 120 mg | ||
| CALAN SR | TABLET, EXTENDED RELEASE | 180 mg | ||
| COVERA-HS | TABLET, EXTENDED RELEASE | 180 mg/24 hours | ||
| ISOPTIN SR | TABLET, EXTENDED RELEASE | 180 mg | ||
| CALAN SR | TABLET, EXTENDED RELEASE | 240 mg | ||
| COVERA-HS | TABLET, EXTENDED RELEASE | 240 mg/24 hours | ||
| ISOPTIN SR | TABLET, EXTENDED RELEASE | 240 MG | ||
| VERAPAMIL HYDROCHLORIDE SR | TABLET, EXTENDED RELEASE | 240 mg |
View Other Therapeutic Options: Calcium-Channel Blocking Agents, Calcium-Channel Blocking Agents, Miscellaneous:
242800, 242892
Last updated: Jul. 8, 2024
- Do Not Crush Sustained release tablets may not be crushed, but are scored and may be broken in half. Sustained release capsules may be opened and contents taken without crushing or chewing.